Clinical Trial

A Phase II Clinical Trial of Efficacy and Safety of SAL0140 at Different Doses in Patients With Uncontrolled Hypertension

Name: A Phase II Clinical Trial of Efficacy and Safety of SAL0140 at Different Doses in Patients With Uncontrolled Hypertension — clinical trial record (NCT07654140)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

This is a multicenter, randomized, double-blind, placebo-controlled phase II study designed to explore the efficacy and safety of different doses of SAL0140 in uncontrolled hypertension.

Trial Details

NCT Number	NCT07654140
Lead Sponsor	Shenzhen Salubris Pharmaceuticals Co., Ltd.
Conditions	Uncontrolled Hypertension
Enrollment	252 participants
Start Date	2025-12-09
Primary Completion	2027-03-01 (estimated)
Study Completion	2027-07-31 (estimated)
Updated on ClinicalTrials.gov	2026-06-17